Cary Street Partners Investment Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Buy |
802
+146
| +22% | +$56.8K | 0.15% | 157 |
|
|
2025
Q1 | $285K | Buy |
656
+21
| +3% | +$9.13K | 0.16% | 153 |
|
|
2024
Q4 | $234K | Sell |
635
-10,799
| -94% | -$3.98M | 0.15% | 153 |
|
|
2024
Q3 | $5.95M | Sell |
11,434
-991
| -8% | -$515K | 0.22% | 111 |
|
|
2024
Q2 | $6.73M | Buy |
12,425
+5
| +0% | +$2.71K | 0.27% | 97 |
|
|
2024
Q1 | $6.44M | Sell |
12,420
-123
| -1% | -$63.8K | 0.27% | 99 |
|
|
2023
Q4 | $5.91M | Buy |
12,543
+471
| +4% | +$222K | 0.28% | 96 |
|
|
2023
Q3 | $5.26M | Sell |
12,072
-288
| -2% | -$125K | 0.28% | 98 |
|
|
2023
Q2 | $5.49M | Sell |
12,360
-139
| -1% | -$61.8K | 0.35% | 75 |
|
|
2023
Q1 | $5.75M | Sell |
12,499
-139
| -1% | -$63.9K | 0.41% | 66 |
|
|
2022
Q4 | $6.48M | Buy |
12,638
+2
| +0% | +$1.03K | 0.48% | 61 |
|
|
2022
Q3 | $5.74M | Buy |
12,636
+1,589
| +14% | +$722K | 0.47% | 59 |
|
|
2022
Q2 | $5.33M | Buy |
+11,047
| New | +$5.33M | 0.45% | 65 |
|
|
2021
Q1 | – | Sell |
-2,873
| Closed | -$923K | – | 345 |
|
|
2020
Q4 | $923K | Buy |
2,873
+2,273
| +379% | +$730K | 0.18% | 128 |
|
|
2020
Q3 | $161K | Buy |
+600
| New | +$161K | 0.03% | 291 |
|